Nurix Therapeutics Inc

NRIXNASDAQ · US

Holders

REDUCEDStale
Ring Christine
Nurix Therapeutics Inc · NASDAQ
−400 sh · $10.7K
Filed 2 Sept 2026SEC Form 4view source
ACQUIREDStale
Ring Christine
Nurix Therapeutics Inc · NASDAQ
+5,787 sh · $50.5K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Ring Christine
Nurix Therapeutics Inc · NASDAQ
−5,387 sh · $138.4K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Hansen Gwenn
Nurix Therapeutics Inc · NASDAQ
−1,452 sh · $37.0K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Hansen Gwenn
Nurix Therapeutics Inc · NASDAQ
+1,452 sh · $2.7K
Filed 1 Sept 2026SEC Form 4view source
DISCLOSEDQuarterly
ARK Investment Management
Nurix Therapeutics Inc · NASDAQ
1,793,196 sh · $43.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Nurix Therapeutics Inc · NASDAQ
1,721,135 sh · $26.7M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Nurix Therapeutics Inc · NASDAQ
118,000 sh · $1.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Nurix Therapeutics Inc · NASDAQ
1,602,539 sh · $30.4M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Nurix Therapeutics Inc · NASDAQ
1,510,404 sh · $14.0M
Filed 30 Sept 2025SEC 13Fview source